Baird Medical Investment Holdings Limited (NASDAQ:BDMD – Get Free Report) was the target of a significant decrease in short interest in June. As of June 30th, there was short interest totaling 33,197 shares, a decrease of 39.8% from the June 15th total of 55,105 shares. Based on an average daily trading volume, of 171,545 shares, the days-to-cover ratio is presently 0.2 days. Approximately 0.4% of the shares of the stock are short sold.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings downgraded Baird Medical Investment from a “sell (d)” rating to a “sell (d-)” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Baird Medical Investment presently has an average rating of “Sell”.
Check Out Our Latest Analysis on BDMD
Baird Medical Investment Stock Performance
Institutional Investors Weigh In On Baird Medical Investment
Large investors have recently bought and sold shares of the stock. Citadel Advisors LLC purchased a new stake in shares of Baird Medical Investment during the third quarter worth approximately $99,000. Jane Street Group LLC acquired a new stake in shares of Baird Medical Investment in the 2nd quarter valued at about $142,000. Finally, Geode Capital Management LLC grew its position in shares of Baird Medical Investment by 59.7% during the second quarter. Geode Capital Management LLC now owns 25,442 shares of the company’s stock worth $93,000 after acquiring an additional 9,511 shares during the last quarter. Hedge funds and other institutional investors own 19.78% of the company’s stock.
Baird Medical Investment Company Profile
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Featured Stories
- Five stocks we like better than Baird Medical Investment
- AI’s Power Crunch Fuels a Pivot for These 2 Oilfield Stocks
- Why Conagra’s Dividend Cut Could Be the Best Thing for Investors
- Japan’s Crypto Overhaul Could Open the Door to a Wave of Institutional Money
- Cintas Keeps Beating Expectations—And the Story Isn’t Over
Receive News & Ratings for Baird Medical Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baird Medical Investment and related companies with MarketBeat.com's FREE daily email newsletter.
